M&A

How Much Could DepoMed Fetch in a Deal?
Motley Fool
Sat, 09/24/16 - 01:34 pm
Depomed
M&A
Takeover Chatter Around Clovis May Be Overdone
TheStreet.com
Fri, 09/23/16 - 10:10 pm
Clovis Oncology
M&A
Eli Lilly
Merck
Takeda
A Device Rep's Story of an Acquisition Gone Wrong (part 1 of 2)
CP Wire
Fri, 09/23/16 - 11:10 am
devices
device reps
sales managers
M&A
Will Gilead Make a Good Fit for Allergan?
Investopedia
Fri, 09/23/16 - 09:56 am
Gilead Sciences
Allergan
M&A
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Fierce Pharma
Thu, 09/22/16 - 09:46 am
Teva Pharmaceutical
Perrigo
Sun Pharma
Bayer
dermatology
M&A
Is Tesaro Another M&A Target? The Charts Say It Is
TheStreet.com
Thu, 09/22/16 - 09:17 am
Tesaro
M&A
Biotech: Why NASH is So Hot Right Now
Barron's
Wed, 09/21/16 - 10:55 pm
NASH
Allergan
M&A
Gilead Sciences
Tobira Therapeutics
Galmed Pharmaceuticals
Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers'
Yahoo/Benzinga
Wed, 09/21/16 - 10:51 pm
Allergan
Gilead Sciences
M&A
Sarepta's New Drug May Make It a Takeover
Investopedia
Wed, 09/21/16 - 10:50 pm
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
M&A
Zombie biotech Eleven Bio seeks resurrection with merger deal
Fierce Biotech
Wed, 09/21/16 - 10:10 am
Eleven Biotherapeutics
M&A
Viventia
How Much Is Depomed Worth As A Buyout Target?
Seeking Alpha
Wed, 09/21/16 - 09:32 am
Depomed
M&A
Ariad Shares Rise Amid Speculation of Potential Buyout
Bloomberg
Tue, 09/20/16 - 08:59 pm
Ariad Pharmaceuticals
M&A
Allergan just acquired two companies in one day
Yahoo/Business Insider
Tue, 09/20/16 - 08:54 pm
Allergan
M&A
liver disease
NASH
Akarna Therapeutics
Tobira Therapeutics
Allergan pays $50 mln to buy privately-held Akarna Therapeutics
Marketwatch
Tue, 09/20/16 - 08:42 pm
Allergan
Akarna Therapeutics
M&A
NASH
Report: Depomed Is Attempting to Sell Itself
Investopedia
Tue, 09/20/16 - 11:06 am
Depomed
M&A
Allergan Buys Tobira for Up to $1.7 Billion to Gain Liver Drug
Bloomberg
Tue, 09/20/16 - 08:56 pm
Allergan
Tobira Therapeutics
M&A
NASH
Bayer raises sales targets for top-selling drugs after Monsanto deal
Yahoo/Reuters
Tue, 09/20/16 - 09:53 am
Bayer
Monsanto
M&A
Xarelto
Eylea
Johnson & Johnson - Finally Putting Money To Work, Sticking With The Conglomerate Model
Seeking Alpha
Mon, 09/19/16 - 06:07 pm
JNJ
Abbott Labs
M&A
Abbott Medical Optics
Pfizer: Hospira Is Future; Xtandi Is Today's Meal
Yahoo/GuruFocus
Mon, 09/19/16 - 06:04 pm
Pfizer
Hospira
Xtandi
M&A
Medivation
Shire wants out of that $172M Baxalta deal with CTI Bio
Endpoints
Mon, 09/19/16 - 06:03 pm
Shire
Baxalta
CTI BioPharma
M&A

Pages